sniff.trade
showstrackprofile
request access
ARK

ARKG

4 tracked calls · 4 long · 0 short · last 90d: 4L/0S
first called by The Ascent 2mo ago
ARKARKGLONG4w ago
“I think ArcG is up 15 maybe 20 since I mentioned it on the podcast... I'm actually still very bullish on these names. I'm not selling out of them... look for the things where AI, like what are the dow”
1000x

Capital is fleeing overheated memory stocks and plowing into downstream AI beneficiaries like ARKG, which already jumped 15% in just two weeks.

ARKARKGLONG@ $43.07
$38.28-11.13%
since call Jul 1
Trade on Robinhood →
ARKARKGLONG1mo ago
“the best looking chart I've seen in a long time is ARKG... This is the base. I mean, we based for freaking 5 years now, 4 years. We're going to break out.”
1000x

As tech giants sink 700 billion into AI infrastructure, investors must hide in biotech funds like ARKG that will actually harvest the real-world gains.

ARKARKGLONG@ $40.27
$38.28-4.94%
since call Jun 24
peak +3.0%
Trade on Robinhood →
ARKARKGLONG1mo ago
“the FDA is a lot more lax courtesy of RFK than it's ever been before... I bought ARKG which is Ark Revolutionary Genomics ETF... I'm going to increase exposure to genomics.”
1000x

A newly lax FDA just triggered an 80 percent vertical spike in a gene therapy stock, so grab Cathie Wood's genomics ETF to ride the AI drug discovery wave.

ARKARKGLONG@ $36.10
$38.28+6.04%
since call Jun 19
peak +12.1%
Trade on Robinhood →
ARKARKGLONG2mo ago
“Alpha: the AI-bio interface is the unlock for the next decade of medical fortunes...”
The Ascent · happyprofit

AI-bio interface is the unlock for the next decade of medical fortunes, market still prices it as venture speculation.

ARKARKGLONG@ $34.63
$38.28+10.52%
since call May 30
peak +19.1%
Trade on Robinhood →